American Healthcare REIT (AHR) Stock: Buy, Sell, or Hold?
AHR - American Healthcare REIT, Inc.
$52.42
-0.11 (-0.21%)
▼
5d:
+6.18%
30d:
-1.26%
90d:
-7.37%
BUY
HIGH Confidence
Analysis Updated: Oct 14, 2026 12:00 AM ET
Earnings: Nov 05, 2026
20d
Get Alerted When AHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AHR appears deeply undervalued. Market expects -3.8% annual earnings decline despite 158% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: AHR appears deeply undervalued. Market expects -3.8% annual earnings decline despite 158% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$48.20
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$29.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AHR is currently trading at $52.42, which is considered fair relative to its 30-day fair value range of $50.84 to $53.35. From a valuation perspective, the stock is trading at a discount (Forward PE: 53.0) compared to its historical average (59.5). Remarkably, the market is currently pricing in an annual earnings decline of 3.8% over the next few years. This pessimistic expectation contrasts with the company's recent 157.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $53.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AHR scores 71/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $63.80 (+21.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $53.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AHR scores 71/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $63.80 (+21.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$50.84 -
$53.35
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (71/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.7% below Wall St target ($63.80)
- BULLISH: Bottoming setup score 71/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$50.84 -
$53.35
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$49.25
Resistance Level
$53.29
Current Trend
Strong Uptrend
Technical data as of
Oct 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
52.95
Wall Street Target
$63.80
(+21.7%)
Revenue Growth (YoY)
24.7%
Earnings Growth (YoY)
157.5%
Profit Margin
4.8%
Valuation Discount vs History
-3.8% cheaper
PE vs Historical
53.0 vs 59.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.8%
(market-implied from PE analysis)
1-Year Target
$50.43
(-4%)
2-Year Target
$48.51
(-8%)
3-Year Target
$46.67
(-11%)
3-Yr Target (if PE normalizes)
(PE: 53→60)
$52.44
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 52.9, Growth: 60.0%)
$176.92
(+238%)
Base:
(SPY PE: 19.9, Growth: 60.0%)
$66.36
(+27%)
Bear:
(PE: 16.9, Growth: 60.0%)
$56.40
(+8%)
📈
Valuation based on Current Earnings
Forward PE: 48.08 | Forward EPS (Implied): $1.09
Bull Case
$63.30
(+21%)
Analyst growth 15.0%, PE expands to 50.5
Base Case
$52.42
(0%)
Market implied 0.0%, PE stable at 48.1
Bear Case
$40.10
(-24%)
Severe decline -15.0%, PE contracts to 43.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 52.9 to 59.5
Stabilization Target:
$58.90
(+12.4%)
PE Expansion Potential:
+12.4%
Share & Embed Analysis
Last updated: October 15, 2026 5:25 AM ET
Data refreshes hourly during market hours. Next update: 6:24 AM
Data refreshes hourly during market hours. Next update: 6:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
23 analysts |
$102 | 65 BUY |
|
WELL
Welltower Inc |
STRONG BUY
22 analysts |
$262 | 60 HOLD |
|
CTRE
CareTrust REIT Inc. |
STRONG BUY
13 analysts |
$45 | 75 BUY |
|
OHI
Omega Healthcare Investo… |
HOLD
20 analysts |
$52 | 63 BUY |
|
DOC
Healthpeak Properties Inc |
HOLD
22 analysts |
$23 | 55 HOLD |
